Vectura Group (LSE:VEC)
Vectura develops inhaled therapies principally for the treatment of respiratory diseases.
About
Last updated 17-05-2019, 05:25:24pm BSTRelated Articles
-
3 under-the-radar healthcare stocks I think have great growth potential
G A Chester highlights three small-cap companies for investors seeking stocks with a higher risk/higher reward profile. Read More »
-
Why I’d invest £1,000 in the Glaxo share price today
Harvey Jones says GlaxoSmithKline plc (LSE: GSK) remains a FTSE 100 (INDEXFTSE: UKX) dividend income hero. Read More »
-
Warning! I reckon this FTSE 100 stock could fall off a cliff in 2019
Rupert Hargreaves thinks it's only a matter of time before this high-flying FTSE 100 (INDEXFTSE: UKX) growth stock falls back to earth. Read More »
-
Why I’d buy this flying FTSE 100 stock today and hold it for decades
This FTSE 100 (INDEXFTSE:UKX) business has outstanding credentials for buy-and-hold investors, says G A Chester. Read More »
-
Could these 2 pharma growth stocks help you retire early?
Harvey Jones sees plenty to like in these two pharmaceutical stocks, but plenty of uncertainties too. Read More »
-
One FTSE 100 income champion and one growth star that could help you retire early
The combination of income and growth from this FTSE 100 (INDEXFTSE: UKX) market leader and its peer could help you retire early. Read More »
-
Two defensive growth stocks I’d buy and hold for 10 years
These two stocks are struggling today but the future could still be bright. Read More »
-
Should I swap GlaxoSmithKline plc for this turnaround stock?
Could this company offer higher returns than GlaxoSmithKline plc (LON:GSK)? Read More »
-
Top stocks for December
We asked our analysts to share their top stock picks for the month. Read More »
-
There could be hidden value in these FTSE 250 stocks
G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX). Read More »
